Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Jan;49(1):15–17. doi: 10.1136/ard.49.1.15

Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor.

A M Boerbooms 1, A A Westgeest 1, P Reekers 1, L B van de Putte 1
PMCID: PMC1003955  PMID: 2310221

Abstract

HLA typing was carried out in 132 patients with rheumatoid arthritis (RA) with long term follow up, and special attention was focused on rheumatoid factor negative patients. The patients were divided into four groups: 55 patients with a seropositive RA and a positive antiperinuclear factor (group A); 39 seropositive patients but a negative antiperinuclear factor (group B); 14 patients consistently seronegative for 3-28 years (mean 11.8 years) but positive for antiperinuclear factor (group C); patients consistently negative for 3-28 years (mean 11.8) and also negative for antiperinuclear factor (group D). The prevalence of HLA-DR4 was 31/55 (56%), 29/39 (74%), 10/14 (71%), and 9/24 (37%) for groups A, B, C, and D respectively, and in all groups was significantly higher than in 277 healthy controls (55/277, 20%). No significant difference was found between seropositive (groups A and B) and seronegative (groups C and D) patients, but groups A, B, and C had higher prevalences than group D. It is concluded that in seronegative RA HLA-DR4 is preferentially associated with the antiperinuclear factor positive group.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calin A., Marks S. H. The case against seronegative rheumatoid arthritis. Am J Med. 1981 May;70(5):992–994. doi: 10.1016/0002-9343(81)90846-9. [DOI] [PubMed] [Google Scholar]
  2. Dobloug J. H., Førre O., Kåss E., Thorsby E. HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum. 1980 Mar;23(3):309–313. doi: 10.1002/art.1780230307. [DOI] [PubMed] [Google Scholar]
  3. Gran J. T., Husby G., Thorsby E. The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis. 1983 Jun;42(3):292–296. doi: 10.1136/ard.42.3.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jaraquemada D., Ollier W., Awad J., Young A., Silman A., Roitt I. M., Corbett M., Hay F., Cosh J. A., Maini R. N. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis. 1986 Aug;45(8):627–636. doi: 10.1136/ard.45.8.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klein F., Bronsveld W., Norde W., Van Romunde L. K., Singer J. M. A modified latex-fixation test for the detection of rheumatoid factors. J Clin Pathol. 1979 Jan;32(1):90–92. doi: 10.1136/jcp.32.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Masi A. T. Rheumatoid factor negative (seronegative) rheumatoid arthritis: evolving clinical classification and immunogenetic associations. J Rheumatol. 1988 Jan;15(1):4–6. [PubMed] [Google Scholar]
  7. NIENHUIS R. L., MANDEMA E. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis. 1964 Jul;23:302–305. doi: 10.1136/ard.23.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PLOTZ C. M., SINGER J. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med. 1956 Dec;21(6):888–892. [PubMed] [Google Scholar]
  9. Panayi G. S., Celinska E., Emery P., Griffin J., Welsh K. I., Grahame R., Gibson T. Seronegative and seropositive rheumatoid arthritis: similar diseases. Br J Rheumatol. 1987 Jun;26(3):172–180. doi: 10.1093/rheumatology/26.3.172. [DOI] [PubMed] [Google Scholar]
  10. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Scherak O., Smolen J. S., Mayr W. R. Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol. 1980 Jan-Feb;7(1):9–12. [PubMed] [Google Scholar]
  12. Sondag-Tschroots I. R., Aaij C., Smit J. W., Feltkamp T. E. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis. 1979 Jun;38(3):248–251. doi: 10.1136/ard.38.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  14. Terkeltaub R., Décary F., Esdaile J. An immunogenetic study of older age onset rheumatoid arthritis. J Rheumatol. 1984 Apr;11(2):147–149. [PubMed] [Google Scholar]
  15. Thomsen M., Morling N., Snorrason E., Svejgaard A., Sørensen S. F. HLA--Dw4 and rheumatoid arthritis. Tissue Antigens. 1979 Jan;13(1):56–60. doi: 10.1111/j.1399-0039.1979.tb01137.x. [DOI] [PubMed] [Google Scholar]
  16. Walton K., Dyer P. A., Grennan D. M., Haeney M., Harris R. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol. 1985 Apr;12(2):223–226. [PubMed] [Google Scholar]
  17. Westgeest A. A., Boerbooms A. M., Jongmans M., Vandenbroucke J. P., Vierwinden G., van de Putte L. B. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol. 1987 Oct;14(5):893–897. [PubMed] [Google Scholar]
  18. Woodrow J. C. Immunogenetics of rheumatoid arthritis. J Rheumatol. 1988 Jan;15(1):1–3. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES